Phyllomedusin
| Internal ID | 1629a634-c843-40b5-af53-721a7b55d1fc |
| Taxonomy | Organic Polymers > Polypeptides |
| IUPAC Name | (2S)-N-[(2S)-1-[[(2S)-1-[[(2S,3S)-1-[[2-[[(2S)-1-[[(2S)-1-amino-4-methylsulfanyl-1-oxobutan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-2-oxoethyl]amino]-3-methyl-1-oxopentan-2-yl]amino]-1-oxo-3-phenylpropan-2-yl]amino]-5-(diaminomethylideneamino)-1-oxopentan-2-yl]-2-[[(2S)-1-[(2S)-4-amino-4-oxo-2-[[(2S)-5-oxopyrrolidine-2-carbonyl]amino]butanoyl]pyrrolidine-2-carbonyl]amino]butanediamide |
| SMILES (Canonical) | |
| SMILES (Isomeric) | |
| InChI | InChI=1S/C52H82N16O13S/c1-6-28(4)42(50(80)59-26-41(72)61-33(22-27(2)3)46(76)62-30(43(55)73)18-21-82-5)67-48(78)34(23-29-12-8-7-9-13-29)64-44(74)31(14-10-19-58-52(56)57)63-47(77)35(24-38(53)69)65-49(79)37-15-11-20-68(37)51(81)36(25-39(54)70)66-45(75)32-16-17-40(71)60-32/h7-9,12-13,27-28,30-37,42H,6,10-11,14-26H2,1-5H3,(H2,53,69)(H2,54,70)(H2,55,73)(H,59,80)(H,60,71)(H,61,72)(H,62,76)(H,63,77)(H,64,74)(H,65,79)(H,66,75)(H,67,78)(H4,56,57,58)/t28-,30-,31-,32-,33-,34-,35-,36-,37-,42-/m0/s1 |
| InChI Key | GGIXGYYACCFXOQ-GUXVTFBTSA-N |
| Popularity | 2 references in papers |
| Molecular Formula | C52H82N16O13S |
| Molecular Weight | 1171.40 g/mol |
| Exact Mass | 1170.59679791 g/mol |
| Topological Polar Surface Area (TPSA) | 501.00 Ų |
| XlogP | -3.20 |
| Atomic LogP (AlogP) | -4.86 |
| H-Bond Acceptor | 15 |
| H-Bond Donor | 14 |
| Rotatable Bonds | 35 |
| 26145-48-2 |
| DTXSID101043460 |
| HY-P3092 |
| CS-0144792 |
| Target | Value | Probability (raw) | Probability (%) |
|---|---|---|---|
| Human Intestinal Absorption | + | 0.9112 | 91.12% |
| Caco-2 | - | 0.8658 | 86.58% |
| Blood Brain Barrier | - | 0.7250 | 72.50% |
| Human oral bioavailability | - | 0.6429 | 64.29% |
| Subcellular localzation | Lysosomes | 0.6025 | 60.25% |
| OATP2B1 inhibitior | - | 0.8581 | 85.81% |
| OATP1B1 inhibitior | + | 0.8144 | 81.44% |
| OATP1B3 inhibitior | + | 0.9340 | 93.40% |
| MATE1 inhibitior | - | 0.5600 | 56.00% |
| OCT2 inhibitior | - | 0.7000 | 70.00% |
| BSEP inhibitior | + | 0.9774 | 97.74% |
| P-glycoprotein inhibitior | + | 0.7446 | 74.46% |
| P-glycoprotein substrate | + | 0.8821 | 88.21% |
| CYP3A4 substrate | + | 0.7471 | 74.71% |
| CYP2C9 substrate | + | 0.5953 | 59.53% |
| CYP2D6 substrate | - | 0.8399 | 83.99% |
| CYP3A4 inhibition | - | 0.9459 | 94.59% |
| CYP2C9 inhibition | - | 0.8137 | 81.37% |
| CYP2C19 inhibition | - | 0.8081 | 80.81% |
| CYP2D6 inhibition | - | 0.8916 | 89.16% |
| CYP1A2 inhibition | - | 0.8791 | 87.91% |
| CYP2C8 inhibition | + | 0.7448 | 74.48% |
| CYP inhibitory promiscuity | - | 0.9891 | 98.91% |
| UGT catelyzed | - | 0.0000 | 0.00% |
| Carcinogenicity (binary) | - | 0.8600 | 86.00% |
| Carcinogenicity (trinary) | Non-required | 0.6420 | 64.20% |
| Eye corrosion | - | 0.9852 | 98.52% |
| Eye irritation | - | 0.8973 | 89.73% |
| Skin irritation | - | 0.7591 | 75.91% |
| Skin corrosion | - | 0.9115 | 91.15% |
| Ames mutagenesis | - | 0.7400 | 74.00% |
| Human Ether-a-go-go-Related Gene inhibition | + | 0.6912 | 69.12% |
| Micronuclear | + | 0.7500 | 75.00% |
| Hepatotoxicity | - | 0.5432 | 54.32% |
| skin sensitisation | - | 0.8453 | 84.53% |
| Respiratory toxicity | + | 0.7556 | 75.56% |
| Reproductive toxicity | + | 0.9111 | 91.11% |
| Mitochondrial toxicity | + | 0.7375 | 73.75% |
| Nephrotoxicity | - | 0.7647 | 76.47% |
| Acute Oral Toxicity (c) | III | 0.6029 | 60.29% |
| Estrogen receptor binding | + | 0.7319 | 73.19% |
| Androgen receptor binding | + | 0.5540 | 55.40% |
| Thyroid receptor binding | + | 0.5517 | 55.17% |
| Glucocorticoid receptor binding | + | 0.6210 | 62.10% |
| Aromatase binding | + | 0.7316 | 73.16% |
| PPAR gamma | + | 0.6636 | 66.36% |
| Honey bee toxicity | - | 0.7146 | 71.46% |
| Biodegradation | - | 0.8000 | 80.00% |
| Crustacea aquatic toxicity | + | 0.5400 | 54.00% |
| Fish aquatic toxicity | + | 0.7439 | 74.39% |
Proven Targets:
| CHEMBL ID | UniProt ID | Name | Min activity | Assay type | Source |
|---|---|---|---|---|---|
| No proven targets yet! | |||||
Predicted Targets (via Super-PRED):
| CHEMBL ID | UniProt ID | Name | Probability | Model accuracy |
|---|---|---|---|---|
| CHEMBL2581 | P07339 | Cathepsin D | 99.99% | 98.95% |
| CHEMBL1795139 | Q8IU80 | Transmembrane protease serine 6 | 99.62% | 98.33% |
| CHEMBL2693 | Q9UIQ6 | Cystinyl aminopeptidase | 99.44% | 97.64% |
| CHEMBL230 | P35354 | Cyclooxygenase-2 | 99.36% | 89.63% |
| CHEMBL4361 | Q07820 | Induced myeloid leukemia cell differentiation protein Mcl-1 | 99.06% | 95.52% |
| CHEMBL3251 | P19838 | Nuclear factor NF-kappa-B p105 subunit | 98.84% | 96.09% |
| CHEMBL204 | P00734 | Thrombin | 98.68% | 96.01% |
| CHEMBL2514 | O95665 | Neurotensin receptor 2 | 98.65% | 100.00% |
| CHEMBL4777 | P25929 | Neuropeptide Y receptor type 1 | 98.31% | 96.67% |
| CHEMBL4123 | P30989 | Neurotensin receptor 1 | 97.71% | 96.67% |
| CHEMBL4588 | P22894 | Matrix metalloproteinase 8 | 97.65% | 94.66% |
| CHEMBL259 | P32245 | Melanocortin receptor 4 | 97.31% | 95.38% |
| CHEMBL5043 | Q6P179 | Endoplasmic reticulum aminopeptidase 2 | 97.13% | 91.81% |
| CHEMBL4979 | P13866 | Sodium/glucose cotransporter 1 | 96.12% | 98.24% |
| CHEMBL2492 | P36544 | Neuronal acetylcholine receptor protein alpha-7 subunit | 96.06% | 88.42% |
| CHEMBL3807 | P17706 | T-cell protein-tyrosine phosphatase | 95.87% | 93.00% |
| CHEMBL3137262 | O60341 | LSD1/CoREST complex | 95.76% | 97.09% |
| CHEMBL3359 | P21462 | Formyl peptide receptor 1 | 95.74% | 93.56% |
| CHEMBL5845 | P23415 | Glycine receptor subunit alpha-1 | 95.59% | 90.71% |
| CHEMBL3837 | P07711 | Cathepsin L | 95.46% | 96.61% |
| CHEMBL237 | P41145 | Kappa opioid receptor | 95.35% | 98.10% |
| CHEMBL1255126 | O15151 | Protein Mdm4 | 95.01% | 90.20% |
| CHEMBL4018 | P49146 | Neuropeptide Y receptor type 2 | 94.76% | 98.94% |
| CHEMBL3108638 | O15164 | Transcription intermediary factor 1-alpha | 94.75% | 95.56% |
| CHEMBL1907591 | P30926 | Neuronal acetylcholine receptor; alpha4/beta4 | 94.59% | 100.00% |
| CHEMBL4644 | P41968 | Melanocortin receptor 3 | 94.10% | 99.52% |
| CHEMBL5619 | P27695 | DNA-(apurinic or apyrimidinic site) lyase | 93.80% | 91.11% |
| CHEMBL221 | P23219 | Cyclooxygenase-1 | 93.71% | 90.17% |
| CHEMBL4478 | Q00975 | Voltage-gated N-type calcium channel alpha-1B subunit | 93.64% | 97.14% |
| CHEMBL3130 | O00329 | PI3-kinase p110-delta subunit | 92.88% | 96.47% |
| CHEMBL4203 | Q9HAZ1 | Dual specificity protein kinase CLK4 | 92.75% | 94.45% |
| CHEMBL3060 | Q9Y345 | Glycine transporter 2 | 92.16% | 99.17% |
| CHEMBL4026 | P40763 | Signal transducer and activator of transcription 3 | 92.03% | 82.69% |
| CHEMBL1944495 | P28065 | Proteasome subunit beta type-9 | 91.39% | 97.50% |
| CHEMBL1907600 | Q00535 | Cyclin-dependent kinase 5/CDK5 activator 1 | 91.31% | 93.03% |
| CHEMBL5939 | Q9NZ08 | Endoplasmic reticulum aminopeptidase 1 | 91.22% | 100.00% |
| CHEMBL1907594 | P30926 | Neuronal acetylcholine receptor; alpha3/beta4 | 90.81% | 97.23% |
| CHEMBL340 | P08684 | Cytochrome P450 3A4 | 90.22% | 91.19% |
| CHEMBL1075094 | Q16236 | Nuclear factor erythroid 2-related factor 2 | 89.39% | 96.00% |
| CHEMBL4394 | Q9NYA1 | Sphingosine kinase 1 | 89.24% | 96.03% |
| CHEMBL2535 | P11166 | Glucose transporter | 89.12% | 98.75% |
| CHEMBL3392948 | Q9NP59 | Solute carrier family 40 member 1 | 88.66% | 95.00% |
| CHEMBL5103 | Q969S8 | Histone deacetylase 10 | 87.84% | 90.08% |
| CHEMBL5701 | Q9H2K8 | Serine/threonine-protein kinase TAO3 | 86.81% | 96.67% |
| CHEMBL2803 | P43403 | Tyrosine-protein kinase ZAP-70 | 86.75% | 82.50% |
| CHEMBL5608 | Q16288 | NT-3 growth factor receptor | 85.94% | 95.89% |
| CHEMBL4608 | P33032 | Melanocortin receptor 5 | 85.27% | 97.00% |
| CHEMBL4227 | P25090 | Lipoxin A4 receptor | 84.88% | 100.00% |
| CHEMBL1907603 | Q05586 | Glutamate NMDA receptor; GRIN1/GRIN2B | 84.70% | 95.89% |
| CHEMBL2069156 | Q14145 | Kelch-like ECH-associated protein 1 | 84.52% | 82.38% |
| CHEMBL4462 | Q8IXJ6 | NAD-dependent deacetylase sirtuin 2 | 84.36% | 90.24% |
| CHEMBL236 | P41143 | Delta opioid receptor | 84.24% | 99.35% |
| CHEMBL5028 | O14672 | ADAM10 | 83.99% | 97.50% |
| CHEMBL4801 | P29466 | Caspase-1 | 83.85% | 96.85% |
| CHEMBL2327 | P21452 | Neurokinin 2 receptor | 83.78% | 98.89% |
| CHEMBL4461 | Q9NTG7 | NAD-dependent deacetylase sirtuin 3 | 82.57% | 94.36% |
| CHEMBL2781 | P19634 | Sodium/hydrogen exchanger 1 | 82.28% | 90.24% |
| CHEMBL3729 | P22748 | Carbonic anhydrase IV | 81.56% | 99.23% |
| CHEMBL255 | P29275 | Adenosine A2b receptor | 81.53% | 98.59% |
| CHEMBL1744525 | P43490 | Nicotinamide phosphoribosyltransferase | 81.29% | 96.25% |
| CHEMBL3310 | Q96DB2 | Histone deacetylase 11 | 81.28% | 88.56% |
| CHEMBL4625 | Q07817 | Apoptosis regulator Bcl-X | 81.18% | 99.77% |
| CHEMBL3024 | P53350 | Serine/threonine-protein kinase PLK1 | 81.08% | 97.43% |
| CHEMBL3176 | O43603 | Galanin receptor 2 | 81.02% | 98.89% |
| CHEMBL4208 | P20618 | Proteasome component C5 | 80.02% | 90.00% |
Below are displayed all the plants proven (via scientific papers) to contain this
compound!
To see more specific details click the taxa you are interested in.
To see more specific details click the taxa you are interested in.
| There are no matching plants. |
| PubChem | 10441328 |
| LOTUS | LTS0097875 |
| wikiData | Q105008136 |